Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 1
2003 2
2004 2
2005 1
2007 1
2009 2
2011 1
2012 2
2013 5
2014 5
2015 7
2016 9
2017 5
2018 6
2019 14
2020 14
2021 10
2022 7
2023 7
2024 4

Text availability

Article attribute

Article type

Publication date

Search Results

89 results

Results by year

Filters applied: . Clear all
Page 1
Perioperative Adriamycin plus ifosfamide vs. gemcitabine plus docetaxel for high-risk soft tissue sarcomas: randomised, phase II/III study JCOG1306.
Tanaka K, Machida R, Kawai A, Nakayama R, Tsukushi S, Asanuma K, Matsumoto Y, Hiraga H, Hiraoka K, Watanuki M, Yonemoto T, Abe S, Katagiri H, Nishida Y, Nagano A, Suehara Y, Kawashima H, Kawano M, Morii T, Hatano H, Toguchida J, Okuma T, Takeyama M, Takenaka S, Akisue T, Furuta T, Emori M, Hiruma T, Outani H, Yamamoto T, Kataoka T, Fukuda H, Ozaki T, Iwamoto Y. Tanaka K, et al. Among authors: yonemoto t. Br J Cancer. 2022 Nov;127(8):1487-1496. doi: 10.1038/s41416-022-01912-5. Epub 2022 Jul 23. Br J Cancer. 2022. PMID: 35871234 Free PMC article. Clinical Trial.
Prognostic factors of metastatic myxoid liposarcoma.
Shinoda Y, Kobayashi E, Kobayashi H, Mori T, Asano N, Nakayama R, Morioka H, Iwata S, Yonemoto T, Ishii T, Hiruma T, Kawai A, Kawano H. Shinoda Y, et al. Among authors: yonemoto t. BMC Cancer. 2020 Sep 14;20(1):883. doi: 10.1186/s12885-020-07384-1. BMC Cancer. 2020. PMID: 32928160 Free PMC article.
Comprehensive molecular and clinicopathological profiling of desmoid tumours.
Kohsaka S, Hirata M, Ikegami M, Ueno T, Kojima S, Sakai T, Ito K, Naka N, Ogura K, Kawai A, Iwata S, Okuma T, Yonemoto T, Kobayashi H, Suehara Y, Hiraga H, Kawamoto T, Motoi T, Oda Y, Matsubara D, Matsuda K, Nishida Y, Mano H. Kohsaka S, et al. Among authors: yonemoto t. Eur J Cancer. 2021 Mar;145:109-120. doi: 10.1016/j.ejca.2020.12.001. Epub 2021 Jan 11. Eur J Cancer. 2021. PMID: 33444924 Free article.
Prognostic Factors for Survival in Patients With High-grade Chondrosarcoma.
Kinoshita H, Kamoda H, Hagiwara Y, Kinoshita S, Ohtori S, Yonemoto T. Kinoshita H, et al. Among authors: yonemoto t. Cancer Diagn Progn. 2022 Nov 3;2(6):681-685. doi: 10.21873/cdp.10159. eCollection 2022 Nov-Dec. Cancer Diagn Progn. 2022. PMID: 36340450 Free PMC article.
Second primary osteosarcomas in patients with retinoblastoma.
Fujiwara T, Fujiwara M, Numoto K, Ogura K, Yoshida A, Yonemoto T, Suzuki S, Kawai A. Fujiwara T, et al. Among authors: yonemoto t. Jpn J Clin Oncol. 2015 Dec;45(12):1139-45. doi: 10.1093/jjco/hyv140. Epub 2015 Oct 4. Jpn J Clin Oncol. 2015. PMID: 26438540
89 results